Kuros Biosciences AG (FRA:YTSN)

Market Cap	1.12B +27.4%
Revenue (ttm)	110.66M +129.8%
Net Income	-6.50M
EPS	-0.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	91.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	28.34
Previous Close	28.32
Day's Range	28.34 - 28.34
52-Week Range	23.32 - 35.32
Beta	n/a
RSI	50.46
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Employees: 158
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: YTSN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial numbers in CHF